Thomas John

Loading... 2 0 20 0 false
Credit Name
Thomas John
Full Name
John, Thomas
 
Variants
John, Tom
 
 
Personal Site
https://www.onjcancercentre.org/profile/a-prof.-tom-john
 
Loading... 3 0 20 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Author:  Mitchell, Paul L R

Results 1-19 of 19 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1Dec-2019RET-rearranged non-small-cell lung cancer and therapeutic implications.Loh, Zoe ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein
2Sep-2019DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it?Arulananda, Surein; Mitchell, Paul L R ; John, Thomas 
3Apr-2019Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas 
4Nov-2017Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
5Sep-2017De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.Thai, Alesha; Chia, Puey L; Russell, Prudence A; Do, Hongdo; Dobrovic, Alexander ; Mitchell, Paul L R ; John, Thomas 
6Aug-2017Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.Tamjid, Babak ; Phan, Phuong L; John, Thomas ; Mitchell, Paul L R ; Gan, Hui K 
7Aug-2017Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextItchins, M; Chia, Puey Ling ; Hayes, SA; Howell, VM; Gill, AJ; Cooper, WA; John, Thomas ; Mitchell, Paul L R ; Millward, M; Clarke, SJ; Solomon, B; Pavlakis, N
822-Apr-2017PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLCAmeratunga, Malaka; Asadi, Khashayar ; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Knight, Simon; Mitchell, Paul L R ; Boutros, Paul; John, Thomas 
92017The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.Thapa, Bibhusal ; Salcedo, Adriana; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Ameratunga, Malaka; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon; Mitchell, Paul L R ; Watkins, D Neil; Boutros, Paul C; John, Thomas 
10Dec-2016Lung cancer in 2016: immunotherapy comes of ageMitchell, Paul L R ; John, Thomas 
11Dec-2016Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.Thapa, Bibhusal ; Walkiewicz, Marzena; Murone, Carmel ; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon R ; Mitchell, Paul L R ; Liew, Danny; Watkins, D Neil; John, Thomas 
1218-Oct-2016Digital PCR of genomic rearrangements for monitoring circulating tumour DNADo, Hongdo; Cameron, Daniel; Molania, Ramyar; Thapa, Bibhusal ; Rivall, Gareth; Mitchell, Paul L R ; Murone, Carmel ; John, Thomas ; Papenfuss, Anthony; Dobrovic, Alexander 
13Aug-2016Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentChia, Puey Ling ; Do, Hongdo; Morey, Adrienne; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
1420-Nov-2014Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
1526-Feb-2014A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander 
164-Nov-2013Should we screen for lung cancer in Australia?Mitchell, Paul L R ; John, Thomas 
1716-Oct-2013Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.Liew, Mun Sem; Sia, Joseph; Starmans, Maud H W; Tafreshi, Ali; Harris, Sam; Feigen, Malcolm; White, Shane C; Zimet, Allan; Lambin, Philippe; Boutros, Paul C; Mitchell, Paul L R ; John, Thomas 
1823-Jul-2013The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S 
191-Oct-2011Bronchoepidural Fistula in a man with actinomycosis complicated non-small cell lung cancer.Sem Liew, Mun; Arulananda, Surein; Seow, James; Mitchell, Paul L R ; John, Thomas